Hemodynamic Improvement as an Additional Parameter to Evaluate the Safety and Tolerability of the Molecular Adsorbent Recirculating System in Liver Failure Patients

Transplantation Proceedings

Volumn 40, Issue 6, 2008, Pages 1925-1928

  Pugliese, F ^a   Novelli, G ^a   Poli, L ^a   Levi Sandri, G B ^a   Di Folco, G ^a   Ferretti, S ^a   Morabito, V ^a   Ruberto, F ^a   Berloco, P B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ALBUMIN DIALYSIS; ARTICLE; BLEEDING; CENTRAL VENOUS CATHETER; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; INFECTION; INTENSIVE CARE; LIVER DYSFUNCTION; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PRURITUS; RETRANSPLANTATION; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VEIN CATHETERIZATION;

ADULT; AGED; BLOOD PRESSURE; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NOREPINEPHRINE; RETROSPECTIVE STUDIES; SAFETY; SORPTION DETOXIFICATION; VASCULAR RESISTANCE;

EID: 48149099377     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.05.077     Document Type: Article

References (10)

1. Ellis A., and Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 16 (1996) 379
2. Schmidt L.E., Sorensen V.R., Svendsen L.B., et al. Hemodynamic changes during a single treatment with the molecular adsorbent recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 7 (2001) 1034
3. Martin P.Y., Ginès P., and Schrier R.W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339 (1998) 533
4. Kjaergard L.L., Liu J., Als-Nielsen B., et al. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 289 (2003) 217
5. Liu J.P., Gluud L.L., Als-Nielsen B., et al. Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev (2004) 1:CD003628
6. Mitzner S.R., Klammt S., Peszynski P., et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 5 (2001) 417
7. Daniluk J., Szuster-Ciesielska A., Drabko J., et al. Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol 23 (2001) 29
8. Nagaki M., Iwai H., Naiki T., et al. High levels of serum interleukin-10 and tumor necrosis factor-α are associated with fatality in fulminant hepatitis. J Infect Dis 182 (2000) 1103
9. Awad S.S., Sawada S., Soldes O.S., et al. Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?. ASAIO J 45 (1999) 47
10. Awad S.S., Swaniker F., Magee J., et al. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 130 (2001) 354